MIM
EOLS icon

MetLife Investment Management’s Evolus EOLS Stock Holding History

MetLife Investment Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
35,080
+16,773
+92% +$99K ﹤0.01% 2319
2026
Q1 		$75.2K Sell
18,307
-10,081
-36% -$48.8K ﹤0.01% 2633
2025
Q4 		$189K Buy
28,388
+2,256
+9% +$15.3K ﹤0.01% 2301
2025
Q3 		$160K Sell
26,132
-7,466
-22% -$58.2K ﹤0.01% 2433
2025
Q2 		$309K Hold
33,598
– – ﹤0.01% 1940
2025
Q1 		$404K Sell
33,598
-674
-2% -$8.81K ﹤0.01% 1822
2024
Q4 		$378K Buy
34,272
+2,044
+6% +$28.7K ﹤0.01% 1951
2024
Q3 		$522K Hold
32,228
– – ﹤0.01% 1762
2024
Q2 		$350K Buy
32,228
+11,602
+56% +$143K ﹤0.01% 1927
2024
Q1 		$289K Buy
20,626
+1,012
+5% +$13.2K ﹤0.01% 1976
2023
Q4 		$207K Hold
19,614
– – ﹤0.01% 2227
2023
Q3 		$179K Hold
19,614
– – ﹤0.01% 2274
2023
Q2 		$143K Hold
19,614
– – ﹤0.01% 2481
2023
Q1 		$166K Hold
19,614
– – ﹤0.01% 2333
2022
Q4 		$147K Hold
19,614
– – ﹤0.01% 2421
2022
Q3 		$158K Hold
19,614
– – ﹤0.01% 2440
2022
Q2 		$228K Hold
19,614
– – ﹤0.01% 2225
2022
Q1 		$220K Buy
+19,614
New +$167K ﹤0.01% 2300
2021
Q4 		– Sell
-2,791
Closed -$21.3K – 2516
2021
Q3 		$21.3K Sell
2,791
-10,150
-78% -$105K ﹤0.01% 2559
2021
Q2 		$164K Buy
+12,941
New +$142K ﹤0.01% 2275
2019
Q4 		– Sell
-7,900
Closed -$123K – 2311
2019
Q3 		$123K Buy
7,900
+2,792
+55% +$45.8K ﹤0.01% 2213
2019
Q2 		$74.7K Sell
5,108
-10,216
-67% -$202K ﹤0.01% 2401
2019
Q1 		$346K Buy
+15,324
New +$331K ﹤0.01% 2252

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

MetLife Investment Management's EOLS Position: Q2 2026 in Review

MetLife Investment Management increased its Evolus (EOLS) stake by 92% in Q2 2026, buying an estimated $99K and bringing the position to 35,080 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

MetLife Investment Management first reported a position in EOLS in Q1 2019 and has held it in 23 quarters since. The position peaked at $522K in Q3 2024. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • MetLife Investment Management held 35,080 shares of Evolus worth $243K as of Q2 2026.
  • MetLife Investment Management bought 16,773 Evolus shares in Q2 2026, an estimated $99K.
  • Evolus made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2319 holding.
  • MetLife Investment Management first reported a position in Evolus in Q1 2019 and has held it in 23 quarters since.
  • MetLife Investment Management's Evolus position peaked at $522K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.